生物可吸收植入市场按材料类型、应用、最终用户和地区划分

2025 年全球生物可吸收植入市场规模预计为 66.3 亿美元，预计到 2032 年将达到 119 亿美元，2025 年至 2032 年的复合年增长率为 8.7%。

数字。 2025 年生物可吸收植入市场占有率（按地区）

生物可吸收植入是设计用于暂时留在体内并在达到预期目的后进行生物分解的医疗设备。生物可吸收植入由聚乳酸（PLLA）或Polyglycolic（PGA）等聚合物製成，会随着时间的推移分解并被人体吸收。这减少了透过侵入性手术移除植入的需要。生物可吸收植入比传统永久性植入具有显着的优势，包括更少的应力遮蔽、逐渐吸收、负荷转移到癒合骨骼以及避免长期併发症。全球生物可吸收植入市场的成长得益于心臟和整形外科疾病盛行率的不断上升、外科手术数量的不断增加、生物可吸收材料相对于永久性植入的优势以及技术进步。

市场动态

全球生物可吸收植入市场发展的关键驱动力是老年人口的增加，老年人更容易罹患心臟疾病和整形外科疾病。根据世界卫生组织估计，到2050年，65岁及以上人口预计将从2010年的5.24亿增加到近15亿。生物可吸收植入可降低永久性植入相关感染疾病的风险，且无需移除植入。这使得它们比传统植入更受欢迎。此外，开发具有客製化降解率以适应每个组织癒合过程的先进可吸收聚合物正在推动市场成长。然而，与金属植入相比，生物可吸收植入的成本更高，且低收入国家对此的认知度较低，这可能会阻碍市场的成长。正在进行的用于软组织修復和药物输送的可吸收植入的研究和开发可以为製造商提供有利可图的机会。

本研究的主要特点

• 本研究报告对全球生物可吸收植入市场进行了详细分析，并提供了预测期（2025-2032）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球生物可吸收植入市场的主要企业是根据公司亮点、产品系列、关键亮点、性能和策略等参数进行的分析。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球生物可吸收植入市场报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过全球生物可吸收植入市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球生物可吸收植入市场 - 冠状病毒 (COVID-19) 疫情的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 全球生物可吸收植入市场（以材料类型），2020-2032 年（十亿美元）

• 介绍
• 金属
• 聚合物

6. 2020-2032 年全球生物可吸收植入市场（按应用划分）（十亿美元）

• 介绍
• 整形外科
• 心血管
• 其他的

7. 2020-2032 年全球生物可吸收植入市场（按最终用户划分）（十亿美元）

• 介绍
• 医院
• 专科门诊
• 门诊手术中心
• 其他的

8. 全球生物可吸收植入市场，按地区，2020-2032 年（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • Abbott Laboratories
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • BIoTronik SE & Co. KG
  • Terumo Corporation
  • Amaranth Medical, Inc.
  • Arthrex, Inc.
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion NV
  • DSM Biomedical
  • WL Gore & Associates, Inc.

第 10 章分析师建议

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Bioresorbable Implants Market is estimated to be valued at USD 6.63 Bn in 2025 and is expected to reach USD 11.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Figure. Bioresorbable Implants Market Share (%), By Region 2025

Bioresorbable implants are medical devices that are designed to remain in the body temporarily and undergo biodegradation after serving their intended purpose. Made from polymers such as polylactic acid (PLLA) and polyglycolic acid (PGA), bioresorbable implants degrade over time and are absorbed by the body. This alleviates the need for subsequent invasive surgery to remove implants. These offer significant benefits over traditional permanent implants by causing less stress shielding, resorbing gradually to transfer load to healing bone, and avoiding long-term complications. Global bioresorbable implants market growth is driven by growing prevalence of cardiac and orthopedic diseases, rising number of surgeries, advantages of bioresorbable materials over permanent implants, and technological advancements.

MARKET DYNAMICS:

Global bioresorbable implants market growth is primarily driven by rising geriatric population who are more prone to develop cardiac diseases and orthopedic disorders. As per WHO, the number of people aged 65 years and above is expected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Bioresorbable implants reduce the risk of permanent implant-related infections and eliminate the need for implant removal. This boosts their demand over conventional implants. Moreover, advanced resorbable polymers with customized degradation rate are being developed to suit individual tissue healing process, thus, driving the market growth. However, high costs of bioresorbable implants as compared to metal implants and lack of awareness in low-income nations can hamper the market growth. Ongoing R&D to develop resorbable implants for soft tissue repair and drug delivery can offer lucrative opportunities for manufacturers.

Key Features of the Study:

• This report provides in-depth analysis of the global bioresorbable implants market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bioresorbable implants market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include DePuy Synthes, Stryker, Smith & Nephew, Zimmer Biomet, Medtronic and Bioretec
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global bioresorbable implants market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioresorbable implants market

Detailed Segmentation-

• By Material Type
  • Metallic
  • Polymer
• By Application
  • Orthopedic
  • Cardiovascular
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott Laboratories
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Terumo Corporation
  • Amaranth Medical, Inc.
  • Arthrex, Inc.
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion N.V.
  • DSM Biomedical
  • WL Gore & Associates, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Material Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bioresorbable Implants Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bioresorbable Implants Market, By Material Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Metallic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Polymer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Bioresorbable Implants Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Orthopedic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Bioresorbable Implants Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Bioresorbable Implants Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Material Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stryker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Zimmer Biomet Holdings, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Smith & Nephew plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biotronik SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Terumo Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amaranth Medical, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arthrex, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bioretec Ltd.
  • REVA Medical, LLC
  • Tepha, Inc.
  • Corbion N.V.
  • DSM Biomedical
  • WL Gore & Associates, Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact